Gender disparities in hematuria evaluation and bladder cancer diagnosis: A population based analysis

Journal of Urology

Volumn 192, Issue 4, 2014, Pages 1072-1077

  Garg, Tullika ^a,b   Pinheiro, Laura C ^a   Atoria, Coral L ^a   Donat, S Machele ^a   Weissman, Joel S ^c   Herr, Harry W ^a   Elkin, Elena B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

female; hematuria; quality of health care; SEER program; urinary bladder neoplasms

Indexed keywords

AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER STAGING; COMORBIDITY; CONSULTATION; CYSTOSCOPY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SEX DIFFERENCE; TREATMENT OUTCOME; URINARY TRACT; URINE CYTOLOGY; URINE INCONTINENCE; URINE RETENTION; CLINICAL TRIAL; COMPLICATION; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; HEALTH CARE QUALITY; HEALTH SURVEY; MULTICENTER STUDY; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; SEX RATIO; SURVIVAL RATE; TIME FACTOR; TRENDS; UNITED STATES; URINARY BLADDER NEOPLASMS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HEMATURIA; HUMANS; MALE; POPULATION SURVEILLANCE; PROGNOSIS; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; SEER PROGRAM; SEX DISTRIBUTION; SEX FACTORS; SURVIVAL RATE; TIME FACTORS; UNITED STATES; URINARY BLADDER NEOPLASMS;

EID: 84921990195     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2014.04.101     Document Type: Article

References (22)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10
2. N.A. Mungan, L.A. Kiemeney, and J.A. van Dijck Gender differences in stage distribution of bladder cancer Urology 55 2000 368
3. P. Hartge, E.B. Harvey, and W.M. Linehan Unexplained excess risk of bladder cancer in men J Natl Cancer Inst 82 1990 1636
4. M. McGrath, D.S. Michaud, and I. De Vivo Hormonal and reproductive factors and the risk of bladder cancer in women Am J Epidemiol 163 2006 236
5. H. Miyamoto, J.L. Yao, and A. Chaux Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder BJU Int 109 2012 1716
6. E.M. Messing Urothelial tumors of the bladder 9th ed. A.J. Wein, L.R. Kavoussi, A.C. Novick, Campbell-Walsh Urology vol 3 2007 Saunders/Elsevier Philadelphia 2407 2446
7. R. Davis, J.S. Jones, and D.A. Barocas Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline J Urol 188 suppl. 2012 2473
8. G.D. Grossfeld, J.S. Wolf Jr., and M.S. Litwin Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations Am Fam Physician 63 2001 1145
9. E.K. Johnson, S. Daignault, and Y. Zhang Patterns of hematuria referral to urologists: does a gender disparity exist? Urology 72 2008 498
10. A.M. Nieder, Y. Lotan, and G.R. Nuss Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey Urol Oncol 28 2010 500
11. A. Henning, M. Wehrberger, and S. Madersbacher Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer? BJU Int 112 2013 68
12. J.L. Warren, C.N. Klabunde, and D. Schrag Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population Med Care 40 suppl. 2002 IV-3
13. R.A. Deyo, D.C. Cherkin, and M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613
14. F.L. Greene, D.L. Page, and I.D. Fleming AJCC Cancer Staging Manual 6th ed. 2002 Springer-Verlag New York
15. P.E. Clark, N. Agarwal, and M.C. Biagioli Bladder cancer J Natl Compr Canc Netw 11 2013 446
16. B.K. Hollenbeck, R.L. Dunn, and Z. Ye Delays in diagnosis and bladder cancer mortality Cancer 116 2010 5235
17. R.F. Sanchez-Ortiz, W.C. Huang, and R. Mick An interval longer than 12 weeks between the diagnosis of muscle-invasion and cystectomy is associated with worse outcome in bladder carcinoma J Urol 169 2003 110
18. K. Elias, R.S. Svatek, and S. Gupta High-risk patients with hematuria are not evaluated according to guideline recommendations Cancer 116 2010 2954
19. K.A. Schulman, J.A. Berlin, and W. Harless The effect of race and sex on physicians' recommendations for cardiac catheterization N Engl J Med 340 1999 618
20. H. Krissi, R. Eitan, and R. Edward Diagnostic delay in secondary care for lower urinary tract and pelvic organ prolapse symptoms in women Arch Gynecol Obstet 286 2012 115
21. R.K. Loo, S.F. Lieberman, and J.M. Slezak Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria Mayo Clin Proc 88 2013 129
22. M.F. Botteman, C.L. Pashos, and A. Redaelli The health economics of bladder cancer: a comprehensive review of the published literature Pharmacoeconomics 21 2003 1315